| For: | Moole H, Patel J, Ahmed Z, Duvvuri A, Vennelaganti S, Moole V, Dharmapuri S, Boddireddy R, Yedama P, Bondalapati N, Uppu A, Vennelaganti P, Puli S. Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists. World J Gastroenterol 2016; 22(39): 8831-8843 [PMID: 27818599 DOI: 10.3748/wjg.v22.i39.8831] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i39/8831.htm |
| Number | Citing Articles |
| 1 |
Won-Tak Choi, Gregory Y. Lauwers, Elizabeth A. Montgomery. Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia. Modern Pathology 2022; 35(8) doi: 10.1038/s41379-022-01056-0
|
| 2 |
Varan Perananthan, Vani J.A. Konda, Cadman L. Leggett. Narrow Band Imaging and Artificial Intelligence for Detection and Characterization of Barrett’s Esophagus Neoplasia. Gastrointestinal Endoscopy Clinics of North America 2026; 36(1) doi: 10.1016/j.giec.2025.05.009
|
| 3 |
Sharmila Subramaniam, Elisabetta Mastrorocco, Mohan Ramchandani, Pradeep Bhandari. Update on the management of Barrett’s neoplasia. Frontline Gastroenterology 2026; 17(e1) doi: 10.1136/flgastro-2026-103740
|
| 4 |
Jagpal Singh Klair, Yousaf Zafar, Navroop Nagra, Arvind R. Murali, Mahendran Jayaraj, Dhruv Singh, Tarun Rustagi, Rajesh Krishnamoorthi. Outcomes of Radiofrequency Ablation versus Endoscopic Surveillance for Barrett’s Esophagus with Low-Grade Dysplasia: A Systematic Review and Meta-Analysis. Digestive Diseases 2021; 39(6) doi: 10.1159/000514786
|
| 5 |
Jon M. Davison, Maulin B. Shah, Christopher Deitrick, Jennifer Chennat, Ken E. Fasanella, Kevin McGrath. Low-grade dysplasia diagnosis ratio and progression metrics identify variable Barrett’s esophagus risk stratification proficiency in independent pathology practices. Gastrointestinal Endoscopy 2018; 88(5) doi: 10.1016/j.gie.2018.06.017
|
| 6 |
Ravi Vissapragada, Norma B. Bulamu, Roger Yazbeck, Jonathan Karnon, David I. Watson. A Markov cohort model for Endoscopic surveillance and management of Barrett’s esophagus. Healthcare Analytics 2024; 6 doi: 10.1016/j.health.2024.100360
|
| 7 |
Rena Yadlapati, Elizabeth Hubscher, Corey Pelletier, Rinu Jacob, Allison Brackley, Shailja Shah. Induction and maintenance of healing in erosive esophagitis in the United States. Expert Review of Gastroenterology & Hepatology 2022; 16(10) doi: 10.1080/17474124.2022.2134115
|
| 8 |
Alexander S. Trukhmanov, Anna V. Paraskevova, Olga A. Storonova, Andrey Б. Пономарев, Anastasia A. Makushina, Vladimir T. Ivashkin. Clinical and morphological features and functional parameters in patients with gastroesophageal reflux disease and Barrett's esophagus. Terapevticheskii arkhiv 2025; 97(8) doi: 10.26442/00403660.2025.08.203299
|
| 9 |
Saurabh Chandan, Smit Deliwala, Babu P. Mohan, Daryl Ramai, Banreet Dhindsa, Jay Bapaye, Lena L. Kassab, Ojasvini Choudhry Chandan, Antonio Facciorusso, Douglas G. Adler. Vonoprazan versus lansoprazole in erosive esophagitis — A systematic review and meta-analysis of randomized controlled trials. Indian Journal of Gastroenterology 2023; 42(4) doi: 10.1007/s12664-023-01384-2
|
| 10 |
Fumiaki Shiratori, Isamu Hoshino, Hisashi Gunji, Nobuhiro Takiguchi, Yoshihiro Nabeya, Hideaki Shimada. A case of Barrett’s esophageal cancer with gastric mucosa-associated lymphoma. Surgical Case Reports 2020; 6(1) doi: 10.1186/s40792-020-00956-0
|
| 11 |
Ravi Vissapragada, Norma B. Bulamu, Christine Brumfitt, Jonathan Karnon, Roger Yazbeck, David I. Watson. Improving cost-effectiveness of endoscopic surveillance for Barrett’s esophagus by reducing low-value care: a review of economic evaluations. Surgical Endoscopy 2021; 35(11) doi: 10.1007/s00464-021-08646-0
|
| 12 |
Barbara Braden, Evonne Jones-Morris. How to get the most out of costly Barrett’s oesophagus surveillance. Digestive and Liver Disease 2018; 50(9) doi: 10.1016/j.dld.2018.04.012
|
| 13 |
Vinicius J. Campos, Guilherme S. Mazzini, José F. Juchem, Richard R. Gurski. Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett’s Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study. Journal of Gastrointestinal Surgery 2020; 24(1) doi: 10.1007/s11605-019-04456-x
|
| 14 |
Henry Badgery, Matthew Read, Nicole N. Winter, Andrew C. F. Taylor, Michael W. Hii. The role of esophagectomy in the management of Barrett's esophagus with high‐grade dysplasia. Annals of the New York Academy of Sciences 2020; 1481(1) doi: 10.1111/nyas.14439
|
| 15 |
Masashi ZUGUCHI, Reijiro SAITO, Yasushi KAWAHARADA, Yosuke KUBOTA, Yoshitaka ENOMOTO, Ken SAITO, Megumi ZUGUCHI, Satsuki TAKAHASHI. A Case of Barrett's Adenocarcinoma Associated with Systemic Sclerosis. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2019; 80(6) doi: 10.3919/jjsa.80.1110
|
| 16 |
John W. Peabody, Jamielyn D.C. Cruz, Divya Ganesan, David Paculdo, Rebecca J. Critchley-Thorne, Sachin Wani, Nicholas J. Shaheen. A Randomized Controlled Study on Clinical Adherence to Evidence-Based Guidelines in the Management of Simulated Patients With Barrett's Esophagus and the Clinical Utility of a Tissue Systems Pathology Test: Results From Q-TAB. Clinical and Translational Gastroenterology 2024; 15(1) doi: 10.14309/ctg.0000000000000644
|
| 17 |
Won-Tak Choi, Jia-Huei Tsai, Peter S Rabinovitch, Thomas Small, Danning Huang, Aras N Mattis, Sanjay Kakar. Diagnosis and risk stratification of Barrett’s dysplasia by flow cytometric DNA analysis of paraffin-embedded tissue. Gut 2018; 67(7) doi: 10.1136/gutjnl-2017-313815
|
| 18 |
Muhannad Sarem, Francisco J. Martínez Cerezo, Maria Lujan Salvia Favieres, Rodolfo Corti. Low-grade dysplasia in Barrett's esophagus: A problematic diagnosis. Gastroenterología y Hepatología 2023; 46(8) doi: 10.1016/j.gastrohep.2022.10.002
|
| 19 |
Andrew J Henn, Kevin Y Song, Amy A Gravely, Hector Mesa, Shahnaz Sultan, Nicholas J Shaheen, Aasma Shaukat, Brian J Hanson. Persistent indefinite for dysplasia in Barrett’s esophagus is a risk factor for dysplastic progression to low-grade dysplasia. Diseases of the Esophagus 2020; 33(9) doi: 10.1093/dote/doaa015
|
| 20 |
Sagar N. Shah, Jennifer M. Kolb. Today's Toolbox for Barrett's Endotherapy. Techniques and Innovations in Gastrointestinal Endoscopy 2023; 25(2) doi: 10.1016/j.tige.2023.02.001
|
| 21 |
K Y Song, A J Henn, A A Gravely, H Mesa, S Sultan, N J Shaheen, A Shaukat, B J Hanson. Persistent confirmed low-grade dysplasia in Barrett's esophagus is a risk factor for progression to high-grade dysplasia and adenocarcinoma in a US Veterans cohort. Diseases of the Esophagus 2019; doi: 10.1093/dote/doz061
|
| 22 |
M. V. Shamal', A. I. Varabei, Zh. G. Maskalik. BARRETT’S ESOPHAGUS: CONTEMPORARY DIAGNOSTIC AND THERAPEUTIC APPROACHES. Hepatology and Gastroenterology 2019; 3(1) doi: 10.25298/2616-5546-2019-3-1-103-108
|
| 23 |
Tony He, Mark Lai, Kiran G Iyer, Sara Vogrin, John L Slavin, Edward H Tsoi, Bronte Holt, Paul Desmond, Andrew CF Taylor. Long-term outcomes of surveillance or endoscopic therapy for low-grade dysplastic Barrett’s according to a selective management algorithm. Endoscopy International Open 2026; 14(CP) doi: 10.1055/a-2778-3907
|
| 24 |
Salih Samo, Ajay Bansal. The Risk of Barrett’s Esophagus Transforming to Esophageal Cancer. Foregut: The Journal of the American Foregut Society 2023; 3(1) doi: 10.1177/26345161221143140
|
| 25 |
Sushilta Pradhan, Bapi Ray Sarkar. An insight into gastroesophageal reflux disease and its management to alternative medicine and lifestyle changes. RPS Pharmacy and Pharmacology Reports 2025; 4(2) doi: 10.1093/rpsppr/rqaf001
|
| 26 |
Lauren Caush, Jody Church, Stephen Goodall, Reginald V Lord. Factors influencing the cost-effectiveness of radiofrequency ablation for Barrett’s esophagus with low-grade dysplasia in Australia. Diseases of the Esophagus 2025; 38(1) doi: 10.1093/dote/doae095
|
| 27 |
Muhannad Sarem, Francisco J. Martínez Cerezo, Maria Lujan Salvia Favieres, Rodolfo Corti. Low-grade dysplasia in Barrett's esophagus: A problematic diagnosis. Gastroenterología y Hepatología (English Edition) 2023; 46(8) doi: 10.1016/j.gastre.2022.10.016
|